EP 3752163 A4 20210407 - PROMOTING IMMUNE RESPONSES
Title (en)
PROMOTING IMMUNE RESPONSES
Title (de)
FÖRDERUNG VON IMMUNREAKTIONEN
Title (fr)
FAVORISATION DE RÉPONSES IMMUNITAIRES
Publication
Application
Priority
- CN 2018091177 W 20180614
- CN 2019090647 W 20190611
Abstract (en)
[origin: WO2019238024A1] Pharmaceutical compositions comprise a 1-ADP-heptose conjugate and may include an immunogen or an immune checkpoint inhibitor, and are used to promote an immune response.
IPC 8 full level
A61K 31/7076 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 47/54 (2017.01); A61P 37/04 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP KR US)
A61K 31/7076 (2013.01 - EP KR); A61K 39/3955 (2013.01 - EP KR); A61K 45/06 (2013.01 - EP KR); A61K 47/549 (2017.07 - EP KR US); A61K 47/55 (2017.07 - KR US); A61K 47/61 (2017.07 - KR); A61P 37/04 (2017.12 - EP KR); C07K 16/2818 (2013.01 - EP KR US); A61K 45/06 (2013.01 - US); A61K 2039/505 (2013.01 - KR); A61K 2300/00 (2013.01 - KR)
C-Set (source: EP)
Citation (search report)
- [XI] EP 2017281 A1 20090121 - KYOWA HAKKO KIRIN CO LTD [JP]
- [XP] WO 2019080898 A1 20190502 - SHANGHAI YAO YUAN BIOTECHNOLOGY CO LTD [CN]
- See references of WO 2019238024A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2019238024 A1 20191219; AU 2019284192 A1 20210128; CA 3103724 A1 20191219; CN 111971049 A 20201120; EP 3752163 A1 20201223; EP 3752163 A4 20210407; JP 2021527133 A 20211011; KR 20210020104 A 20210223; SG 11202012496X A 20210128; US 11229707 B2 20220125; US 2020405869 A1 20201231
DOCDB simple family (application)
CN 2019090647 W 20190611; AU 2019284192 A 20190611; CA 3103724 A 20190611; CN 201980025130 A 20190611; EP 19818829 A 20190611; JP 2021518839 A 20190611; KR 20217000953 A 20190611; SG 11202012496X A 20190611; US 202017022073 A 20200915